Earth Science Tech, Inc. (ETST) stock
ETSTOTCPharmaceutical PreparationsFiscal year ends March 31
$0.09+0.00 (+3.73%)
Close on Oct 19, 2026Market cap $25.57MP/E 9.8Yield –
Earth Science Tech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Earth Science Tech's operating income for the twelve months ending Dec 31, 2024 was $2.38M, up 318.4% year over year. For fiscal 2024 it was $892.35K. The highest annual figure on record is $892.35K in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Mar 31, 2024 | $892.35K | – |
| FY2023 | Mar 31, 2023 | -$936.68K | – |
| FY2022 | Mar 31, 2022 | -$226.71K | – |
| FY2021 | Mar 31, 2021 | -$4.30M | – |
| FY2020 | Mar 31, 2020 | -$908.57K | – |
| FY2019 | Mar 31, 2019 | -$2.14M | – |
| FY2018 | Mar 31, 2018 | -$1.71M | – |
| FY2015 | Mar 31, 2015 | -$8.77M | – |
| FY2014 | Mar 31, 2014 | -$12.54M | – |
| FY2013 | Mar 31, 2013 | -$61.50K | – |
| FY2012 | Mar 31, 2012 | -$22.78K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.34M | +419.2% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $226.23K | -2.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $829.56K | +72.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $1.07M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $258.49K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $231.03K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $479.94K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$22.98K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$119.32K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$48.28K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$76.91K | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$692.17K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$68.02K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$100.95K | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$46.19K | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$11.54K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$190.28K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$81.45K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$4.03M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$3.87M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$131.99K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$196.88K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$237.57K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$342.12K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$493.29K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$520.22K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$608.08K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$518.13K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$581.38K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$538.19K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$248.49K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$340.82K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$266.40K | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$652.22K | – |
See a number that looks wrong?